VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
QTTB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
QTTBQ32 Bio Inc.
$13.98$179M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksQTTBQuarterly Financials

Q32 Bio Inc. (QTTB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Q32 Bio Inc. (QTTB) quarterly income statement — complete revenue, gross profit & net income history

QTTB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue053.74M0000000-14.66M1.86M3.21M
Revenue Growth %-----100%-100%-100%-100%-1928.18%131.8%299.63%
Cost of Goods Sold90K90K091K0120K0121K123K0124K124K
COGS % of Revenue-0.17%--------6.67%3.87%
Gross Profit-90K53.65M0-91K0-120K0-121K-123K-14.66M1.74M3.08M
Gross Margin %-99.83%-------100%93.33%96.13%
Gross Profit Growth %-44805.83%-24.79%100%99.18%-100%-103.93%-104.36%-8775.74%938.92%19156.25%
Operating Expenses7.63M7.77M7.58M9.08M12.23M14.53M18.81M17.8M14.72M11.15M9.53M10.36M
OpEx % of Revenue-14.46%--------76.03%512.8%323.12%
Selling, General & Admin4.5M4.54M4.02M4.01M5.1M3.98M4.47M4.39M4.88M2.81M2.07M2.34M
SG&A % of Revenue-8.45%--------19.15%111.35%72.98%
Research & Development3.22M3.31M3.56M5.16M7.12M10.54M14.35M13.41M9.84M8.34M7.46M8.02M
R&D % of Revenue-6.17%--------56.87%401.45%250.14%
Other Operating Expenses-90K-90K0-91K00000000
Operating Income-7.72M45.88M-7.58M-9.17M-12.23M-14.53M-18.81M-17.92M-14.84M-25.81M-7.8M-7.28M
Operating Margin %-85.38%-------176.03%-419.47%-226.99%
Operating Income Growth %36.85%415.84%59.73%48.82%17.62%43.72%-141.27%-146.31%-101.32%25.18%76.27%74.3%
EBITDA-7.63M45.97M-7.49M-9.08M-12.11M-14.41M-18.69M-17.8M-14.72M-25.68M-7.67M-7.15M
EBITDA Margin %-85.54%-------175.18%-412.8%-223.12%
EBITDA Growth %36.97%419.1%59.95%48.98%17.74%43.91%-143.56%-148.89%-103.15%24.15%76.19%74.02%
D&A (Non-Cash Add-back)90K90K91K91K119K120K123K121K123K124K124K124K
EBIT-7.72M45.88M-7.09M-9.19M-10.73M6.59M-18.81M-17.92M1.71M-25.81M-13.47M-5.41M
Net Interest Income-200K200K200K-300K400K900K900K2.39M158K1.18M1.42M1.51M
Interest Income0400K500K0700K900K1.2M4.09M658K1.18M1.42M1.51M
Interest Expense200K200K300K300K300K0300K1.7M500K000
Other Income/Expense113K11.85M188K-318K1.2M358K1.22M2.39M15.87M-1M-6.17M1.47M
Pretax Income-7.61M57.73M-7.39M-9.49M-11.03M-14.17M-17.59M-15.53M1.03M-26.81M-13.97M-5.81M
Pretax Margin %-107.43%-------182.88%-751.26%-181.19%
Income Tax0000021K01.45M0253K65K0
Effective Tax Rate %0%0%0%0%0%-0.15%0%-9.33%0%-0.94%-0.47%0%
Net Income-7.61M57.73M-7.39M-9.49M-11.03M-14.19M-17.59M-16.98M1.03M-27.07M-14.03M-5.81M
Net Margin %-107.43%-------184.61%-754.76%-181.19%
Net Income Growth %31.02%506.86%58.01%44.11%-1172.01%47.58%-25.4%-192.37%115.05%21.08%58.4%80.04%
Net Income (Continuing)-7.61M57.73M-7.39M-9.49M-11.03M-14.19M-17.59M-16.98M1.03M-27.07M-14.03M-5.81M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-0.544.58-0.60-0.78-0.90-1.16-1.46-1.420.09-5.00-10.25-10.91
EPS Growth %40%494.83%58.9%45.07%-1142.87%76.8%85.76%86.98%100.96%53.45%3.03%-19.63%
EPS (Basic)-0.544.60-0.60-0.78-0.90-1.16-1.46-1.420.09-5.00-10.25-10.91
Diluted Shares Outstanding14.1M12.59M12.24M12.2M12.2M12.2M12.08M11.96M11.94M3.22M3.21M3.21M
Basic Shares Outstanding14.1M12.56M12.24M12.2M12.2M12.2M12.08M11.96M11.94M3.22M3.21M3.21M
Dividend Payout Ratio------------